Market Research Logo

MediPoint: Central Vascular Access Devices - Global Analysis and Market Forecasts

MediPoint: Central Vascular Access Devices - Global Analysis and Market Forecasts

Summary

Central vascular devices, particularly catheters, have been a mainstay of modern medicine for the last 40 years. These devices are intended for patients with both acute and chronic diseases such as systemic infections, which require catheters that are able to be situated comfortably and confidently within a patient’s venous system for extended periods of time.

The report analyses the market at a category (PICC, Non-tunneled, tunneled, port, hemodialysis catheters and Huber needles) and subcategory level (E.G. antimicrobial vs non-antimicrobial and acute vs chronic hemodialysis catheters) highlighting trends and issues affecting utilization, volume and value of central access devices at a country level.

Key topics discussed include the increasing utilization of PICCs thanks to the development of nurse led implantations and the reasons for the slow adoption of antimicrobial technologies within major markets.

Highlights

Key Questions Answered

  • What is the current and future outlook of the central vascular access devices in developed and emerging markets?
  • What are unmet needs in the central vascular access devices market? What are the clinical and non-clinical barriers in this space? What is hampering innovation within this market?
  • What trends are affecting the global central vascular access devices market?
Scope
  • Competitive assessment: Currently marketed central vascular access devices products and evolving competitive landscape
  • In-depth analysis of practice patterns and adoption trends of different segments and sub-segments of central vascular access devices
  • Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
  • Other key topics covered include utilization trends, market access, reimbursement considerations, and implications for the overall market
  • Market share analysis of the competition in different regions
  • Annualized Individual and cumulative sales units and market revenues for the PICC (Antimicrobial vs Non-antimicrobial), Non-tunneled (Antimicrobial vs Non-antimicrobial), Tunneled, Implantable Ports, Hemodialysis catheters (Chronic vs Acute) and Huber needles market from 2012-2022
Reasons to buy

The report will enable you to -
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline
  • Develop business strategies by understanding the trends shaping and driving the global market
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
  • Track device sales in the global market from 2012-2022
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
3 Industry Overview
3.1 Central Venous Catheters
3.1.1 Peripherally Inserted Central Catheter
3.1.2 Non-tunneled Catheters
3.1.3 Tunneled Catheters
3.1.4 Implantable Ports
3.1.5 Hemodialysis Catheters
3.2 Technological Assessment
3.3 Mergers, Acquisitions, and Key Partnerships
4 Market Access
4.1 Reimbursement
4.1.1 North America and Brazil
4.1.2 5EU
4.1.3 Asia-Pacific
4.2 Regulatory Issues/Recalls
5 Unmet Needs
5.1 Catheter Related Complications
5.1.1 Catheter Related Infections
5.1.2 Catheter Related Thrombosis
5.1.3 Other Complications: Arrhythmia, Phlebitis, and Venous Air Embolism
5.2 Expansion of Non-physician Led Central Vascular Catheter Placement
5.3 Lack of Devices For Pediatric Populations
6 Competitive Assessment
6.1 Company Share Analysis
6.1.1 Global Central Vascular Catheter Devices Market Share
6.1.2 Global Acute Central Vascular Catheter Devices (Non-tunneled) Market Share
6.1.3 Global Peripherally Inserted Central Catheter Market Share
6.1.4 Global Hemodialysis Catheter Market Share
6.2 Peripherally Inserted Central Catheters (Antimicrobial and Non-antimicrobial)
6.2.1 Overview
6.3 Non-tunneled Catheters (Antimicrobial and Non-antimicrobial)
6.3.1 Overview
6.4 Tunneled Catheters
6.4.1 Overview
6.5 Implantable Ports and Huber Needles
6.5.1 Overview
6.6 Chronic and Acute Hemodialysis Catheters
6.6.1 Overview
7 Company Profiles
7.1 Overview
7.2 AngioDynamics
7.2.1 Overview
7.2.2 Marketed Products Assessment
7.2.3 SWOT Analysis
7.3 Argon Medical Devices
7.3.1 Overview
7.3.2 Marketed Products Assessment
7.3.3 SWOT Analysis
7.4 B. Braun Melsungen AG
7.4.1 Overview
7.4.2 Market Products Assessment
7.4.3 SWOT Analysis
7.5 Cook Medical
7.5.1 Overview
7.5.2 Marketed Products Assessment
7.5.3 SWOT Analysis
7.6 Covidien (Medtronic)
7.6.1 Overview
7.6.2 Marketed Products Assessment
7.6.3 SWOT Analysis
7.7 C. R. Bard
7.7.1 Overview
7.7.2 Marketed Products Assessment
7.7.3 SWOT Analysis
7.8 Edwards
7.8.1 Overview
7.8.2 Marketed Products Assessment
7.8.3 SWOT Analysis
7.9 Gambro
7.9.1 Overview
7.9.2 Marketed Product Assessment
7.9.3 SWOT Analysis
7.10 Medcomp
7.10.1 Overview
7.10.2 Marketed Product Assessment
7.10.3 SWOT Analysis
7.11 Navilyst Medical
7.11.1 Overview
7.11.2 Marketed Products Assessment
7.11.3 SWOT Analysis
7.12 Perouse Medical
7.12.1 Overview
7.12.2 Marketed Products Assessment
7.12.3 SWOT Analysis
7.13 Smiths Medical
7.13.1 Overview
7.13.2 Marketed Products Assessment
7.13.3 SWOT Analysis
7.14 Teleflex
7.14.1 Overview
7.14.2 Marketed Products Assessment
7.14.3 SWOT Analysis
7.15 Vygon
7.15.1 Overview
7.15.2 Marketed Products Assessment
7.15.3 SWOT Analysis
7.16 Other Companies
8 Market Outlook
8.1 Procedure Trends
8.1.1 Global Central Vascular Catheter Procedures
8.1.2 Global Hemodialysis Patients (New and Existing)
8.2 Market Drivers and Barriers
8.2.1 Driver: Growing Global Population and Growing Aging Population
8.2.2 Driver: Increasing Financial Power of Developing Countries
8.2.3 Driver: Increasing Burden of Chronic Conditions
8.2.4 Driver: Nurse-Led Peripherally Inserted Central Catheter Placement
8.2.5 Driver: Central Vascular Catheter Placement Protocols
8.2.6 Driver: Technological Advances
8.2.7 Driver: Interventional Radiology
8.2.8 Barrier: Safety Concerns and Product Recalls
8.2.9 Barrier: Clinical Evidence
8.2.10 Barrier: Healthcare Cost-Cutting
8.2.11 Barrier: Medical Device Excise Tax
8.3 Market Outlook by Segment
8.3.1 Global Central Vascular Catheter Devices Market
8.3.2 Global Central Vascular Catheter Devices Market Value by Segment
8.3.3 Global Peripherally Inserted Central Catheter Sub-segment Market Value
8.3.4 Global Non-tunneled Catheters Sub-segment Market Value
8.3.5 Global Hemodialysis Catheters Sub-segment Market Value
8.4 Market Outlook by Geography
8.4.1 US
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 UK
8.4.7 Japan
8.4.8 China
8.4.9 India
8.4.10 Brazil
9 Appendix
9.1 Bibliography
9.2 Abbreviations
9.3 Methodology
9.3.1 Overview
9.3.2 Coverage
9.3.3 Secondary Research
9.4 Forecasting Methodology
9.5 Primary Research Efforts
9.5.1 Physician Survey
9.6 About the Authors
9.6.1 Amen Sanghera, Analyst, Medical Devices (Author)
9.6.2 Linda Tian, Managing Analyst, Research and Analysis, Medical Devices
9.6.3 Tyler Fletcher, Global Head of Medical Devices
9.7 About GlobalData
9.8 Disclaimer
1.1 List of Tables
Table 1: Overview of Vascular Access Devices, 2016 Table 2: Indications for HD catheter placement Table 3: Advantages and Disadvantages of CVC Devices Table 4: Technology used with CVC catheters Table 5: Mergers, Acquisitions, and Key Partnerships, 2012-2016 Table 6: North America and Brazil’s Reimbursement Agencies Table 7: 5EU Reimbursement Agencies Table 8: APAC Reimbursement Agencies Table 9: Product Recalls, 2014-2016 Table 10: Marketed PICC Products Table 11: Marketed Non-tunneled Catheter Products Table 12: Marketed Tunneled Catheter Products Table 13: Marketed Implantable Ports Table 14: Marketed Huber Needles Table 15: Marketed Acute HD Catheters Table 16: Marketed Chronic HD Catheters Table 17: Company Profile - AngioDynamics Table 18: AngioDynamics’ Marketed CVCs Table 19: SWOT Analysis - AngioDynamics Table 20: Company Profile - Argon Medical Devices Table 21: Argon Medical’s Marketed CVC Devices Table 22: SWOT Analysis - Argon Medical Devices Table 23: Company Profile - B. Braun Table 24: B. Braun Marketed CVCs Table 25: SWOT Analysis - B. Braun Table 26: Company Profile - Cook Medical Table 27: Cook Medical Marketed CVCs Table 28: SWOT Analysis - Cook Medical Table 29: Company Profile - Covidien Table 30: Covidien Marketed CVCs Table 31: SWOT Analysis - Covidien Table 32: Company Profile - C. R. Bard Table 33: C. R. Bard Marketed CVCs Table 34: SWOT Analysis - C. R. Bard Table 35: Company Profile - Edwards Table 36: Edwards Marketed CVCs Table 37: SWOT Analysis - Edwards Table 38: Company Profile - C. R. Bard Table 39: Gambro Marketed CVCs Table 40: SWOT Analysis - Gambro Table 41: Company Profile - Medcomp Table 42: Medcomp Marketed CVCs Table 43: SWOT Analysis - Medcomp Table 44: Company Profile - Navilyst Table 45: Navilyst Marketed CVCs Table 46: SWOT Analysis - Navilyst Table 47: Company Profile - Perouse Medical Table 48: Perouse Medical Marketed CVCs Table 49: SWOT Analysis - Perouse Medical Table 50: Company Profile - Smiths Medical Table 51: Smiths Medical Marketed CVCs Table 52: SWOT Analysis - Smiths Medical Table 53: Company Profile - Teleflex Table 54: Teleflex Marketed CVCs Table 55: SWOT Analysis - Teleflex Table 56: Company Profile - Vygon Table 57: Vygon Marketed CVCs Table 58: SWOT Analysis - Vygon Table 59: Other Companies Involved in the CVC Devices Market Table 60: Global CVC Patient Procedures, 2012-2022 Table 61: Global HD Patients Receiving CVCs (New and Existing), 2012-2022 Table 62: Keystone ICU Project Checklist and Considerations Table 63: Global CVC Devices Market Value ($m), 2012-2022 Table 64: Global CVC Devices Market Value ($m), by Segment, 2012-2022 Table 65: Global PICC Market Value ($m), by Sub-segment, 2012-2022 Table 66: Global Non-tunneled Catheters Market Value ($m), by Sub-segment, 2012-2022 Table 67: Global HD Catheters Market Value ($m), by Sub-segment, 2012-2022 Table 68: US CVC Devices Market Value ($m), by Segment, 2012-2022 Table 69: France CVC Devices Market Value ($m), by Segment, 2012-2022 Table 70: Germany CVC Devices Market Value ($m), by Segment, 2012-2022 Table 71: Italy CVC Devices Market Value ($m), by Segment, 2012-2022 Table 72: Spain CVC Devices Market Value ($m), by Segment, 2012-2022 Table 73: UK CVC Devices Market Value ($m), by Segment, 2012-2022 Table 74: Japan CVC Devices Market Value ($m), by Segment, 2012-2022 Table 75: China CVC Devices Market Value ($m), by Segment, 2012-2022 Table 76: India CVC Devices Market Value ($m), by Segment, 2012-2022 Table 77: Brazil CVC Devices Market Value ($m), by Segment, 2012-2022 Table 78: Physicians Surveyed, By Country
1.2 List of Figures
Figure 1: PICC Line Overview
Figure 2: Non-tunneled Catheter Overview
Figure 3: Tunneled Catheter Overview
Figure 4: Implantable Port Overview
Figure 5: Huber Needle Overview
Figure 6: Global CVC Devices Market Share, 2015
Figure 7: Global Acute CVC Market Share, 2015
Figure 8: Global PICC Devices Market Share, 2015
Figure 9: Global HD Catheters Market Share, 2015
Figure 10: Global CVC Patient Procedures, 2012-2022
Figure 11: Global CVC Patient Procedures, by Country, 2012-2022
Figure 12: Global CVC Patient Procedures, Breakdown by Country, 2015 and 2022
Figure 13: Global HD Patients Receiving CVCs (New and Existing), 2012-2022
Figure 14: Global HD Patients Receiving CVCs (New and Existing), by Country, 2012-2022
Figure 15: Global HD Patients Receiving CVCs (New and Existing), Breakdown by Country, 2015 and 2022
Figure 16: Global CVC Devices Market Value ($m), 2012-2022
Figure 17: Global CVC Devices Market Value, Percentage Breakdown, by Country, 2015 and 2022
Figure 18: Global CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 19: Global CVC Devices Market Value , Percentage Breakdown by Segment, 2012 and 2015
Figure 20: Global PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 21: Global PICC Market Value, Percentage Breakdown, by Sub-segment, 2015 and 2022
Figure 22: Global Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 23: Global Non-tunneled Catheters Market Value, Percentage Breakdown, by Sub-segment, 2015 and 2022
Figure 24: Global HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 25: Global HD Catheters Market Value, Percentage Breakdown, by Sub-segment, 2015 and 2022
Figure 26: US CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 27: US PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 28: US Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 29: US HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 30: France CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 31: France PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 32: France Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 33: France HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 34: Germany CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 35: Germany PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 36: Germany Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 37: Germany HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 38: Italy CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 39: Italy PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 40: Italy Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 41: Italy HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 42: Spain CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 43: Spain PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 44: Spain Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 45: Spain HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 46: UK CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 47: UK PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 48: UK Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 49: UK HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 50: Japan CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 51: Japan PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 52: Japan Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 53: Japan HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 54: China CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 55: China PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 56: China Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 57: China HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 58: India CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 59: India PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 60: India Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 61: India HD Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 62: Brazil CVC Devices Market Value ($m) by Segment, 2012-2022
Figure 63: Brazil PICC Market Value ($m) by Sub-segment, 2012-2022
Figure 64: Brazil Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022
Figure 65: Brazil HD Catheters Market Value ($m) by Sub-segment, 2012-2022

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report